AXL and cancer: In a comparison to AXL with an established role in enhancing resistance to ICB, CYTH4, DENND1C, AOAH, EPSTI1, and TBC1D10C display a stronger correlation with immune checkpoints in human cancers (Additional file 14: Fig S14).